OBJECTIVES: To explore the National Survey of Clinical Pharmacy Practice in Saudi Arabia with an emphasis on the Performances and Activities

METHODS: It is a 4-months cross-sectional National Survey of Clinical Pharmacy Practice in Saudi Arabia. The study consisted of two parts; the demographic information and the second part contained fifty-one questions divided into four domains derived from American Society of Health-System Pharmacists, and Saudi Pharmaceutical Society survey, the international standard of Joint Commission of Hospital Accreditation in addition to the local standards of Saudi Center of healthcare accreditation. The four domains were clinical pharmacy administration, and management, performances and activities, education and training, and workload documentation. An electronic questionnaire distributed to the thirty-one directors of pharmacies. The study discussed and analyzed National Survey of Clinical Pharmacy Practice at hospitals in Saudi Arabia: Performances and activities.

RESULTS: The survey questionnaire distributed to 31 hospitals. The most specifications of clinical pharmacy services provided were Concurrent, routine monitoring of drug therapy of the patients 17 (54.84%) and written of medication history 16 (51.61%). The most clinical services existed was answering drug information inquiries (74.19%), Error and adverse drug event reporting (70.97%), and Medication administration (70.97%). The most pharmacy units had clinical pharmacy services was Control and Narcotics system 4.13 (82.60%), Unit dose system 4.07 (81.40%) and Adults emergency medication 3.45 (69%). The most hospital programs had clinical services existed was Stewardship Antimicrobial (64.52%), Medication safety (61.29%), and Medication reconciliation/history-taking (54.84%).

CONCLUSIONS: The performances of clinical pharmacy services were monitoring of drug therapy only. The clinical pharmacist had the inadequate prescribing privilege. Targeting of upgrading the clinical pharmacy performances and privilege is higher recommended with new Saudi vision 2030 to improve patient clinical outcome and avoid any economic burden of the healthcare system in Saudi Arabia.